Form 10-Q Sientra, Inc. For: Jun 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
0,167$
-22,15%
Echtzeit-Aktienkurs Sientra Inc.
Bid:
Ask:
Nachrichten zur Sientra Inc. Aktie
Sientra (SIEN) Reports Q2 Loss, Lags Revenue Estimates
Sientra (SIEN) delivered earnings and revenue surprises of 3.41% and 7.48%, respectively, for the quarter ended June 2023. Do the…
Form 8-K Sientra, Inc. For: Aug 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023
IRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics…
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company…
Form 8-K Sientra, Inc. For: Jun 15
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sientra Announces Appointment of Alexander W. Casdin to Board of Directors
IRVINE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical…
As Sientra Options Become Less Bullish This Week, Short Sellers Are Moving In
Sientras put/call ratio is significantly less bullish than it was last week....…
Dow Edges Lower; Sientra Shares Spike Higher
U.S. stocks traded pared some gains midway through trading, with Dow Jones turning lower on Friday.
The Dow traded down 0.07%…
Sientra, ContraFect top healthcare gainers; Elevation, Longboard among losers
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Stocks to Watch: Sientra, Elevation Oncology, Unico American
Stocks to Watch: Sientra, Elevation Oncology, Unico American...…
Sientra stock rockets ~75% after hours on FDA approval for tissue expander
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sientra Shares up 32% After FDA Clears AlloX2 Pro Tissue Expander
Sientra Shares up 32% After FDA Clears AlloX2 Pro Tissue Expander...…
Sientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue Expander
Significant Milestone as the First, and Only, MRI-Compatible Tissue Expander Available on the US Market...…
Why Fast-paced Mover Sientra (SIEN) Is a Great Choice for Value Investors
Sientra (SIEN) made it through our Fast-Paced Momentum at a Bargain screen and could be a great choice for investors…
Despite Fast-paced Momentum, Sientra (SIEN) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sientra…
Sientra wins FDA nod for Portfinder Technology
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sientra Announces FDA-Clearance of Novel Portfinder™ Technology
Continued Innovation Showcases Sientras Leadership in Reconstruction Surgeries Continued Innovation Showcases Sientras Leadership in Reconstruction Surgeries...…
Form 10-Q Sientra, Inc. For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Sientra, Inc. For: May 11
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sientra to Report First Quarter 2023 Financial Results on May 11, 2023
IRVINE, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical…
Rumble, Braze rise; Virgin Orbit, Sientra fall
Stocks that traded heavily or had substantial price changes Friday: Rumble, Braze rise; Virgin Orbit, Sientra fall...…
Sientra GAAP EPS of -$2.35 misses by $1.01, revenue of $25.07M misses by $0.13M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market With New Product Launches
Continued 2+ year trend of consecutive record quarterly growth; fastest growing brand in the US breast market...…
Will Sientra (SIEN) Report Negative Earnings Next Week? What You Should Know
Sientra (SIEN) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Aziyo, Sientra team up to expand distribution of SimpliDerm
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sientra to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023
IRVINE, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical…
Sientra Announces Preliminary Results from Clinical Study and The First Shipment of Viality™ Fat Transfer System
Data Supports Enhanced Viability of Fat in Breast Augmentation and Reconstruction Using the Viality System Data Supports Enhanced Viability of Fat…
XFRA : Deletion of Instruments from Boerse Frankfurt - 23.01.2023
The following instruments on Boerse Frankfurt do have their last trading day on 23.01.2023
Die folgenden Instrumente in Boerse Frankfurt haben…
Sientra Shares Slip 13% on Trading Following Reverse Split
Sientra Shares Slip 13% on Trading Following Reverse Split...…
XFRA : ISIN Change
Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
CA83085J2011 Sky Gold Corp. 23.01.2023 CA83085J3001 Sky Gold Corp. 24.01.2023 Tausch 3:1
US82621J1051 Sientra Inc. 23.01.2023 US82621J2042 Sientra Inc. 24.01.2023 Tausch 10:1
US67401P1084 Oaktree Specialty Lending Corp. 23.01.2023 US67401P4054 Oaktree Specialty Lending Corp. 24.01.2023 Tausch…
XFRA : S0Z: Aussetzung/Suspension
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME …
XFRA : INSTRUMENT_SUSPENSION - US82621J1051
Instrument ID [10864] (S0Z - US82621J1051) suspended...…
Sientra Announces 1-for-10 Reverse Stock Split
IRVINE, Calif., Jan. 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical…